STAAR SURGICAL CO·4

Mar 10, 7:05 PM ET

LeBuhn Richard T. 4

4 · STAAR SURGICAL CO · Filed Mar 10, 2026

Research Summary

AI-generated summary of this filing

Updated

STAAR SURGICAL (STAA) Director Richard LeBuhn Receives Option Award

What Happened Richard T. LeBuhn, a director of STAAR SURGICAL CO (STAA), was granted 7,524 stock option awards on March 6, 2026. The grant is reported as a derivative award with a transaction price of $0.00 (i.e., no cash paid for the grant). These are option awards rather than immediate share issuances.

Key Details

  • Transaction date: March 6, 2026; Form 4 filed March 10, 2026 (appears timely—filed within two business days).
  • Security: 7,524 options granted (reported as derivative securities; transaction code A = Award/Grant).
  • Price reported: $0.00 (typical for awards/grants).
  • Vesting: Options vest and become exercisable on the earlier of (a) June 18, 2026 or (b) the date of STAAR Surgical’s 2026 annual meeting, subject to LeBuhn’s continuous service (Footnote F1).
  • Plan: Granted under the Issuer’s Amended and Restated Omnibus Equity Incentive Plan (Footnote F2).
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Filing status: No late filing flag noted in the supplied data.

Context This transaction is a director compensation award (options) and is different from an open-market purchase or sale—options vest on a stated schedule and do not immediately change market holdings until exercised. Such grants are common for board compensation and do not, by themselves, indicate a personal buy or sell decision.

Insider Transaction Report

Form 4
Period: 2026-03-06
Transactions
  • Award

    OPTION TO PURCHASE COMMON STOCK

    [F2][F1]
    2026-03-06+7,5247,524 total
    Exercise: $18.46Exp: 2036-03-05COMMON STOCK (7,524 underlying)
Footnotes (2)
  • [F1]These options will vest and become exercisable on the earlier of: (a) June 18, 2026 and (b) the date of STAAR Surgical Company's (the "Issuer") 2026 annual meeting of shareholders, subject, in each case, to Richard T. LeBuhn's (the "Reporting Person") continuous service with the Issuer.
  • [F2]These options were granted to the Reporting Person by the Issuer on March 6, 2026 as director compensation pursuant to the Issuer's Amended and Restated Omnibus Equity Incentive Plan, as amended.
Signature
Richard T. LeBuhn, /s/ Richard T. LeBuhn|2026-03-10

Documents

1 file
  • 4
    ownership.xmlPrimary